Search

Carib A. Oquendo

Examiner (ID: 10644, Phone: (571)270-7411 , Office: P/3678 )

Most Active Art Unit
3678
Art Unit(s)
3672, 3678
Total Applications
952
Issued Applications
718
Pending Applications
72
Abandoned Applications
184

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6161234 [patent_doc_number] => 20110159496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA' [patent_app_type] => utility [patent_app_number] => 12/440283 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 29540 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159496.pdf [firstpage_image] =>[orig_patent_app_number] => 12440283 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/440283
MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA Sep 5, 2007 Abandoned
Array ( [id] => 4456902 [patent_doc_number] => 07893214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Humanized antibodies that recognize beta amyloid peptide' [patent_app_type] => utility [patent_app_number] => 11/842023 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 42833 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893214.pdf [firstpage_image] =>[orig_patent_app_number] => 11842023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/842023
Humanized antibodies that recognize beta amyloid peptide Aug 19, 2007 Issued
Array ( [id] => 4675645 [patent_doc_number] => 20080213274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY, AND NEOVASCULARIZATION CONDITIONS OF THE EYE' [patent_app_type] => utility [patent_app_number] => 11/841363 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 35082 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213274.pdf [firstpage_image] =>[orig_patent_app_number] => 11841363 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/841363
COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY, AND NEOVASCULARIZATION CONDITIONS OF THE EYE Aug 19, 2007 Abandoned
Array ( [id] => 6289862 [patent_doc_number] => 20100158902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST STROMAL DERIVED FACTOR-1 (SDF-1)' [patent_app_type] => utility [patent_app_number] => 12/377015 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 37654 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158902.pdf [firstpage_image] =>[orig_patent_app_number] => 12377015 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/377015
Monoclonal antibodies against stromal derived factor-1 (SDF-1) Aug 9, 2007 Issued
Array ( [id] => 5464401 [patent_doc_number] => 20090324601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/376052 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 154284 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324601.pdf [firstpage_image] =>[orig_patent_app_number] => 12376052 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/376052
TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF Aug 1, 2007 Abandoned
Array ( [id] => 4704523 [patent_doc_number] => 20080064047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS' [patent_app_type] => utility [patent_app_number] => 11/829323 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12166 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064047.pdf [firstpage_image] =>[orig_patent_app_number] => 11829323 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/829323
METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS Jul 26, 2007 Abandoned
Array ( [id] => 4745258 [patent_doc_number] => 20080089860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Therapeutic compositions and methods useful in treating cancer' [patent_app_type] => utility [patent_app_number] => 11/812471 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 43891 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089860.pdf [firstpage_image] =>[orig_patent_app_number] => 11812471 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/812471
Therapeutic compositions and methods useful in treating cancer Jun 18, 2007 Abandoned
Array ( [id] => 5125489 [patent_doc_number] => 20070237760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Detection and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/811590 [patent_app_country] => US [patent_app_date] => 2007-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10288 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237760.pdf [firstpage_image] =>[orig_patent_app_number] => 11811590 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/811590
Detection and treatment of cancer Jun 10, 2007 Abandoned
Array ( [id] => 7724433 [patent_doc_number] => 08097704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Antibody specifically binding to DR5 and composition for preventing or treating cancers comprising the same' [patent_app_type] => utility [patent_app_number] => 12/307293 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 38 [patent_no_of_words] => 8292 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097704.pdf [firstpage_image] =>[orig_patent_app_number] => 12307293 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/307293
Antibody specifically binding to DR5 and composition for preventing or treating cancers comprising the same May 30, 2007 Issued
Array ( [id] => 7595450 [patent_doc_number] => 07626011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Antibodies against tumor surface antigens' [patent_app_type] => utility [patent_app_number] => 11/802989 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25206 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/626/07626011.pdf [firstpage_image] =>[orig_patent_app_number] => 11802989 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/802989
Antibodies against tumor surface antigens May 28, 2007 Issued
Array ( [id] => 4555349 [patent_doc_number] => 07842291 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-11-30 [patent_title] => 'Methods and compositions for diagnosing and treating diseases' [patent_app_type] => utility [patent_app_number] => 11/802321 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 41111 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842291.pdf [firstpage_image] =>[orig_patent_app_number] => 11802321 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/802321
Methods and compositions for diagnosing and treating diseases May 21, 2007 Issued
10/565751 Engineered and Energized Fusion Protein Fv-Ldp-Ae With Potent Antitumor Efficacy and Antiangiogenic Activity and Use Thereof May 2, 2007 Abandoned
Array ( [id] => 4859127 [patent_doc_number] => 20080267977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Combined immunological agent and sensitizing agent for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/796517 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9036 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267977.pdf [firstpage_image] =>[orig_patent_app_number] => 11796517 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/796517
Combined immunological agent and sensitizing agent for the treatment of cancer Apr 25, 2007 Abandoned
Array ( [id] => 5209955 [patent_doc_number] => 20070248539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'AgRM2 antigen' [patent_app_type] => utility [patent_app_number] => 11/789376 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17547 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248539.pdf [firstpage_image] =>[orig_patent_app_number] => 11789376 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/789376
AgRM2 antigen Apr 22, 2007 Abandoned
Array ( [id] => 4443831 [patent_doc_number] => 07862812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Methods for decreasing immune response and treating immune conditions' [patent_app_type] => utility [patent_app_number] => 11/784417 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20036 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/862/07862812.pdf [firstpage_image] =>[orig_patent_app_number] => 11784417 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/784417
Methods for decreasing immune response and treating immune conditions Apr 5, 2007 Issued
Array ( [id] => 16925322 [patent_doc_number] => 11046784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Methods for controlling blood pharmacokinetics of antibodies [patent_app_type] => utility [patent_app_number] => 12/295039 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17658 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12295039 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/295039
Methods for controlling blood pharmacokinetics of antibodies Mar 29, 2007 Issued
Array ( [id] => 5198665 [patent_doc_number] => 20070297983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Inhibition of breast carcinoma stem cell growth and metastasis' [patent_app_type] => utility [patent_app_number] => 11/724884 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4421 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20070297983.pdf [firstpage_image] =>[orig_patent_app_number] => 11724884 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/724884
Inhibition of breast carcinoma stem cell growth and metastasis Mar 15, 2007 Abandoned
Array ( [id] => 216795 [patent_doc_number] => 07611703 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-11-03 [patent_title] => 'Kidney disease targets and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/717149 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42469 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611703.pdf [firstpage_image] =>[orig_patent_app_number] => 11717149 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/717149
Kidney disease targets and uses thereof Mar 12, 2007 Issued
Array ( [id] => 7593512 [patent_doc_number] => 07651687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/717545 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 77548 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/651/07651687.pdf [firstpage_image] =>[orig_patent_app_number] => 11717545 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/717545
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Mar 12, 2007 Issued
Array ( [id] => 4669779 [patent_doc_number] => 20080044839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Methods and compositions for diagnosing lung cancer' [patent_app_type] => utility [patent_app_number] => 11/715642 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 41543 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044839.pdf [firstpage_image] =>[orig_patent_app_number] => 11715642 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/715642
Methods and compositions for diagnosing lung cancer Mar 7, 2007 Issued
Menu